A number of other brokerages have also recently commented on SAN. HSBC Holdings plc set a €81.00 ($94.19) target price on Sanofi SA and gave the company a neutral rating in a report on Wednesday, August 30th. J P Morgan Chase & Co set a €95.00 ($110.47) target price on Sanofi SA and gave the company a neutral rating in a report on Thursday, June 22nd. Jefferies Group LLC set a €87.00 ($101.16) target price on Sanofi SA and gave the company a neutral rating in a report on Thursday, August 24th. Goldman Sachs Group, Inc. (The) set a €82.00 ($95.35) target price on Sanofi SA and gave the company a neutral rating in a report on Monday, August 7th. Finally, Kepler Capital Markets set a €89.00 ($103.49) target price on Sanofi SA and gave the company a buy rating in a report on Wednesday, July 26th. One analyst has rated the stock with a sell rating, eleven have issued a hold rating and five have given a buy rating to the stock. Sanofi SA has an average rating of Hold and an average target price of €87.24 ($101.44).
Shares of Sanofi SA (SAN) traded up €0.58 ($0.67) during midday trading on Wednesday, hitting €79.60 ($92.56). 1,790,000 shares of the stock traded hands, compared to its average volume of 1,840,000. Sanofi SA has a one year low of €70.94 ($82.49) and a one year high of €92.97 ($108.10).
Sanofi SA Company Profile
Sanofi is a healthcare company, focused on patient needs and engaged in the research, development, manufacture and marketing of therapeutic solutions. The Company’s segments are Pharmaceuticals, Human Vaccines (Vaccines), and Other. The Pharmaceuticals segment comprises the commercial operations of various franchises, including Speciality Care (Rare Diseases, Multiple Sclerosis, and Oncology), Diabetes and Cardiovascular, Established Prescription Products, Consumer Healthcare and Generics, and research and development, production and marketing activities for all of the Company’s pharmaceuticals operations.
Receive News & Ratings for Sanofi SA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sanofi SA and related companies with our FREE daily email newsletter.